Nureca Ltd (NURECA)

₹271.85▲1.89%

Get free price alerts. Set up your Free investment account to get Live Prices. >

Overview

Fundamentals

Q3 '23 Results

Technicals

News and Events

Nureca Ltd share Performance

₹270
₹277.95
₹271.85
0.68%
Low
Day's Volatility:2.92%
High
2.24%
₹253.5
₹468.8
₹271.85
6.75%
Low
52 Weeks Volatility:79.20%
High
72.45%

Returns %
1 Month Return	-0.59 %
3 Month Return	-20.62 %
1 Year Return	-16.36 %

Market Stats
Previous Close	₹₹277.10
Open	₹₹270.00
Volume	₹20.20K
Upper Circuit	₹-
Lower Circuit	₹-
Market Cap	₹₹277.10Cr

Company Information

Nureca Ltd. is a leading healthcare and wellness company with a product range of over 150 SKUs across different categories. Formerly known as Nureca Private Limited in India, the company got converted to a Public Limited Company in 2020 and is engaged in the home healthcare and wellness business. It holds over 100 design products and sells its products through Flipkart, Amazon and its own website. Their flagship brand, Dr. Trust enjoys high credibility and loyal customer base with their products being USFDA, European CE, ROHS and ISO certified. Some of the initiatives taken by them in the past included setting up of 3 flex centers in 2017, adding 3 flex centers in 2019 & 2020, taking the effect of demerger as per a scheme of arrangement in 2020 and also receiving prestigious Economic Times Best Healthcare Brands Award 2021.

Share Price: ₹271.85 per share as on 16 May, 2024 04:01 PM
Market Capitalisation: ₹277.10Cr as of today
Revenue: ₹22.37Cr as on December 2023 (Q4 23)
Net Profit: ₹0.17Cr as on December 2023 (Q4 23)
Listing date: 25 Feb, 2021
Chairperson Name: Saurabh Goyal

Organisation	Nureca Ltd
Headquarters
Industry	E-Commerce/App based Aggregator
E-voting on shares	Click here to vote

Key events for Nureca Ltd

Nureca Ltd Shares Dip 26%, P/S Ratio Middle-of-the-Road Compared to Industry - 29 Mar, 2024
Despite a substantial dip in price, Nureca's P/S ratio of 2.7x seems middle-of-the-road compared to the Indian Medical Equipment industry's median P/S ratio of around 2.3x. However, revenue has deteriorated over the last year, which may cause concern for existing shareholders.

Fundamentals of Nureca Ltd

Insights on Nureca Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 63.24% of holdings in Mar 2024 quarter
NO EFFECT
FII Holding Unchanged
Foreign Institutions holdings remained unchanged at 0.08% of holdings in Mar 2024 quarter
NO EFFECT
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 36.67% of holdings in Mar 2024 quarter
NO EFFECT
Against Peers
In the last 3 years, Shree Pacetronix Ltd has given 1872.6% return, outperforming this stock by 1954.5%
NO EFFECT
Against Peers
In the last 1 year, Poly Medicure Ltd has given 71.1% return, outperforming this stock by 87.5%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 34.55 Cr → 28.28 Cr (in ₹), with an average decrease of 18.2% per quarter
NEGATIVE IMPACT
Price Dip
In the last 6 months, NURECA stock has moved down by -24.2%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 2.89 Cr → 0.17 Cr (in ₹), with an average decrease of 94.1% per quarter